Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Feb 18;8(1):24.
doi: 10.3390/pathogens8010024.

Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group

Affiliations

Maternal and Congenital Toxoplasmosis: Diagnosis and Treatment Recommendations of a French Multidisciplinary Working Group

François Peyron et al. Pathogens. .

Abstract

Women infected with toxoplasmosis during pregnancy do not present symptoms in most cases, but the consequences of the congenital infection may be severe for the unborn child. Fetal damage can range from asymptomatic to severe neurological alterations to retinal lesions prone to potential flare up and relapses lifelong. Despite the possible severity of outcome, congenital toxoplasmosis (CT) is a neglected disease. There is no consensus regarding screening during pregnancy, prenatal/postnatal treatment or short or medium term follow-up. Since 1992, France has offered systematic serological testing to non-immune pregnant women, monthly until delivery. Any maternal infection is thus detected; moreover, diagnosis of congenital infection can be made at birth and follow-up can be provided. "Guidelines" drawn up by a multidisciplinary group are presented here, concerning treatment, before and after birth. The recommendations are based on the regular analysis of the literature and the results of the working group. The evaluation of the recommendations takes into account the robustness of the recommendation and the quality of the evidence.

Keywords: congenital toxoplasmosis; follow-up of congenital infection; guidelines; treatment of fetal infections.

PubMed Disclaimer

Conflict of interest statement

F.P. runs reference centers for toxoplasmic serology funded by Abbott and Siemens companies.

Similar articles

Cited by

References

    1. Peyron F., Mc Leod R., Ajzenberg D., Contopoulos-Ioannidis D., Kieffer F., Mandelbrot L., Sibley L.D., Pelloux H., Villena I., Wallon M., et al. Congenital Toxoplasmosis in France and the United States: One Parasite, Two Diverging Approaches. PLoS Negl. Trop. Dis. 2017;11:e0005222. doi: 10.1371/journal.pntd.0005222. - DOI - PMC - PubMed
    1. Rudin C., Hirsch H.H., Spaelti R., Schaedelin S., Klimkait T. Decline of Seroprevalence and Incidence of Congenital Toxoplasmosis Despite Changing Prevention Policy—Three Decades of Cord-blood Screening in North-western Switzerland. Pediatr. Infect. Dis. J. 2018;37:1087–1092. doi: 10.1097/INF.0000000000001978. - DOI - PubMed
    1. Wolters Kluver Grading Guide. [(accessed on 14 May 2018)]; Available online: https://www.uptodate.com/home/grading-guide.
    1. Peyron F., Wallon M., Kieffer F., Garweg J. Toxoplasmosis. In: Remington J.S., Klein J.O., editors. Infectious Diseases of the Fetus and Newborn Infant. Elsevier Saunders; Philadelphia, PA, USA: 2016. pp. 949–1042.
    1. Shwab E.K., Zhu X.-Q., Majumdar D., Pena H.F.J., Gennari S.M., Dubey J.P., Su C. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141:453–461. doi: 10.1017/S0031182013001844. - DOI - PubMed

LinkOut - more resources